Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00482872 · ClinicalTrials.gov registry record
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 400
- Enrollment target
NCT00482872 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 400 participants.
The verdict
NCT00482872 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
RATIONALE: Studying gene mutations in samples of DNA from patients with head and neck cancer and a family history of cancer may help doctors learn more about the development of cancer in families. PURPOSE: This clinical trial is studying germline mutations in patients with head and neck cancer and a family history of cancer.
Interventions
- GENETIC gene expression analysis
- GENETIC mutation analysis
- GENETIC polymerase chain reaction
- OTHER flow cytometry
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2004-03 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00482872
The ClinicalTrials.gov registry entry for NCT00482872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00482872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00482872 about?
NCT00482872 is a clinical study titled "Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer". RATIONALE: Studying gene mutations in samples of DNA from patients with head and neck cancer and a family history of cancer may help doctors learn more about the development of cancer in families. PURPOSE: This clinical trial is studying germline mutations in patients with head and neck cancer and ...
What is the current status of trial NCT00482872?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2004-03. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00482872?
The interventions under investigation include: gene expression analysis (GENETIC), mutation analysis (GENETIC), polymerase chain reaction (GENETIC), flow cytometry (OTHER), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT00482872?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.